Genetics and Age-Related Eye Disease Study Formulation Interaction in Neovascular Age-Related Macular Degeneration
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Purpose: This work aims to determine whether previously defined genotype risk groups interact with Age-Related Eye Disease Study formulation (AREDS-F) use in progression to neovascular age-related macular degeneration (nvAMD). Methods: We conducted a case-only study of 265 nvAMD patients. Patients were anonymously genotyped at the complement factor H and age-related maculopathy susceptibility 2 loci and segregated into genotype groups (GTGs) defined by specific combinations of risk alleles. Physicians, who were blind to patients’ GTGs, obtained patients’ AREDS-F use history. The facility performing genetic analysis was blind to the AREDS-F use history. We used logistic analysis to estimate the interaction coefficient between AREDS-F use and GTG 2 vs GTG 3 in a general-population model. Results: The odds ratio of numbers of patients reporting prior AREDS-F use to nonuse for GTG 2 vs GTG 3 was 4.18 ( P = .001). Logistic regression, correcting for nongenetic risk factors, gave an estimate of the β for interaction of AREDS-F with genotype of 1.57 ( P = .001). This estimates a corrected odds ratio associated with the effect of interaction of 4.81 between those in GTG 2 compared with those in GTG 3. Conclusions: Our data indicate an interaction between GTGs and AREDS-F use that is consistent in size and direction with previously published reports, which had found that using AREDS-F supplements significantly increases the risk of nvAMD for some users and significantly protects other users.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“More recently, a case-only series of 265 patients with neovascular AMD (not analyzed in AREDS or AREDS 2) using an AREDS formulation also reported an interaction between CFH, ARMS2, and clinical outcomes [68].”
From Genetics and Age-Related Macular Degeneration: A Practical Review for Clinicians. (2024) · cites this paper as [68]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of Age-Related Macular Degeneration in the United States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.564 · Cited by 2,736
Age-related macular degeneration
Jager, R. D., Mieler, W. F., & Miller, J. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0801537 · Cited by 1,379
Pennington, K. L., & DeAngelis, M. M. (2016) · Eye and Vision · doi:10.1186/s40662-016-0063-5 · Cited by 480 · cited 1×
“Age-related macular degeneration (AMD) is the leading cause of visual disability in the industrialized world and the third leading cause globally.(1) AMD preferentially damages the macula, the central region of the retina.”
BackgroundPiegorsch, W. W., Weinberg, C. R., & Taylor, J. A. (1994) · Statistics in Medicine · doi:10.1002/sim.4780130206 · Cited by 479 · cited 3×
“Unlike a casecontrol study, in which exposures are compared between individuals with a condition and those without, a case-only study evaluates only individuals with the condition.(20) A statistical interaction between 2 variables, in this case GTG and AREDS-F use, can be estimated if there is no significant interdepe…”
BackgroundMethodAge-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA
Fritsche, L. G., Loenhardt, T., Janssen, A., Fisher, S. A., Rivera, A., Keilhauer, C. N., & Weber, B. H. F. (2008) · Nature Genetics · doi:10.1038/ng.170 · Cited by 400 · cited 1×
“We defined the risk ARMS2 genotype as the 30 insertion/deletion polymorphism (indel), associated previously with ARMS2 RNA instability.(22) Awh et al described the scientific rationale for the GTGs.”
MethodDetection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker–Based Risk Score
Van Neste, L., Hendriks, R. J., Dijkstra, S., Trooskens, G., Cornel, E. B., Jannink, S. A., de Jong, H., Hessels, D., Smit, F. P., Melchers, W. J. G., et al. (2016) · European Urology · doi:10.1016/j.eururo.2016.04.012 · Cited by 370 · cited 1×
“One alternate approach to assess whether there is an interaction between 2 independent variables is a case-only design, the validity of which has been established.(19,20) Unlike a casecontrol study, in which exposures are compared between individuals with a condition and those without, a case-only study evaluates only…”
BackgroundAge-Related Macular Degeneration Preferred Practice Pattern®
Flaxel, C. J., Adelman, R. A., Bailey, S. T., Fawzi, A., Lim, J. I., Vemulakonda, G. A., & Ying, G.-S. (2020) · Ophthalmology · doi:10.1016/j.ophtha.2019.09.024 · Cited by 349
Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration
Seddon, J. M., Francis, P. J., George, S., Schultz, D. W., Rosner, B., & Klein, M. L. (2007) · JAMA · doi:10.1001/jama.297.16.1793 · Cited by 330
Cited by
Genetics and Age-Related Macular Degeneration: A Practical Review for Clinicians.
Nguyen, J., Brantley, & Schwartz, S. G. (2024) · Frontiers in Bioscience-Scholar · doi:10.31083/j.fbs1601003 · Cited by 12
“More recently, a case-only series of 265 patients with neovascular AMD (not analyzed in AREDS or AREDS 2) using an AREDS formulation also reported an interaction between CFH , ARMS2 , and clinical outcomes [68].”
Background
Metadata
- Authors
- Kaufman, S. R., Yoganathan, P., Small, K. W., Rusia, D., Pachydaki, S. I., Conti, S. M., Wenz, R. E., Gersman, M. A., Shaya, F. S., & Kustra, R.
- Affiliations
- Canton City School District (US)
- University of Toronto (CA)
- Macula and Retina Institute (US)
- Corresponding author
- Kaufman, Stephen R.
- Venue
- Journal of VitreoRetinal Diseases
- Publisher
- SAGE Publications
- Published
- 2020-08-19
- Volume
- 5
- Issue
- 1
- Pages
- 46-52
- ISSN
- 2474-1264 (ISSN-L)
- 2474-1272
- PMC
- PMC9976046
- OpenAlex
- W3068863914
- Cited by
- 1
- References
- 30
- Citations by year
- 2024: 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of VitreoRetinal Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- neovascular age-related macular degeneration, genotype-phenotype interaction, complement factor H, APOE ε4, risk alleles, dietary supplements, disease progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genetics and Age-Related Eye Disease Study Formulation Interaction in Neovascular Age-Related Macular Degeneration. https://app.cochat.ai/papers/10.1177/2474126420941713
- The paper
- Kaufman, S. R., Yoganathan, P., Small, K. W., Rusia, D., Pachydaki, S. I., Conti, S. M., Wenz, R. E., Gersman, M. A., Shaya, F. S., & Kustra, R. (2021). Genetics and Age-Related Eye Disease Study Formulation Interaction in Neovascular Age-Related Macular Degeneration. Journal of VitreoRetinal Diseases. https://doi.org/10.1177/2474126420941713
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.